Modulation of soluble guanylate cyclase activity by phosphorylation

Neurochemistry International

Volumn 45, Issue 6, 2004, Pages 845-851

  Murthy, Karnam S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP dependent protein kinase; cBIMPS; cGMP dependent protein kinase; PKA; PKG; PKI; protein kinase inhibitor (14 22) amide; SGC; SNP; sodium nitroprusside; soluble guanylyl cyclase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIC GMP; GUANYLATE CYCLASE; ISOPRENALINE; KT 5823; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OKADAIC ACID; PROTEIN KINASE;

CONCENTRATION RESPONSE; CONFERENCE PAPER; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEEDBACK SYSTEM; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; STOMACH MUSCLE;

CARBAZOLES; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; ENZYME INHIBITORS; GUANYLATE CYCLASE; HUMANS; INDOLES; MUSCLE, SMOOTH; NITRIC OXIDE DONORS; NITROPRUSSIDE; OKADAIC ACID; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; RADIOIMMUNOASSAY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SOLUBILITY; STOMACH; THIONUCLEOTIDES;

EID: 4243083085     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2004.03.014     Document Type: Conference Paper

References (33)

1. Andreopoulos, S., Papapetropoulos., 2000. Molecular aspects of soluble guanylyl cyclase. Gen. Pharmacol. 34, 147-157.
2. Corbin J.D., Francis S.H. Cyclic GMP phosphodiesterase-5: target of sildenafil. J. Biol. Chem. 274:1999;13729-13732
3. Dousa T.P. Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int. 55:1999;29-62
4. Ekholm D., Belfrage P., Manganiello V., Degerman E. Protein kinase A-dependent activation of PDE4 (cAMP-specific nucleotide phosphodiesterase) in cultured bovine vascular smooth muscle cells. Biochimica Biophysica Acta. 1356:1997;64-70
5. Ferrero R., Rodriguez-Pascual F., Miras-Portugal M.T., Torres M. Nitric oxide-sensitive guanylyl cyclase activity inhibition through cGMP-dependent dephosphorylation. J. Neurochem. 75:2000;2029-2039
6. Fillippov G., Bloch D.B., Bloch K.D. Nitric oxide decreases stability of mRNAa encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cell. J. Clin. Invest. 100:1997;942-948
7. Friebe A., Koesling D. Regulation of nitric oxide-sensitive guanylate cylase. Circulation Res. 93:2003;96-105
8. Gupta G., Azam M., Danzier R.S. The β2 subunit inhibits stimulation of the α1/β1 form of soluble guanylyl cyclase by nitric oxide. J. Clin. Invest. 100:1997;1488-1492
9. Hobbs A.J. Soluble guanylate cylcase: the forgotten sibling. Trends Pharmacol. Sci. 18:1997;484-491
10. Hoffmann R., Wilkinson I.R., McCallum J.F., Engles P., Houslay M.D. cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation of and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model. Biochem. J. 333:1998;139-149
11. Iwami G., Kawabe J., Ebina T., Cannon P.J., Homcy C.J., Ishikawa Y. Regulation of adenylyl cylcase by protein kinase A. J. Biol. Chem. 270:1995;12481-12484
12. Jiang H., Colbran J.L., Francis S.H., Corbin J.D. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J. Biol. Chem. 267:1992;1015-1019
13. Jin J.-G., Murthy K.S., Grider J.R., Makhlouf G.M. Activation of distinct cAMP-and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Am. J. Physiol. 264:1993;G470-G477
14. Koesling D. Studying the structure and regulation of soluble guanylate cyclase. Methods. 19:1999;485-493
15. Lee, Y.-C., Martin, E., Murad., 2000. Human recombiant soluble guanylyl cyclase: expression, purification, and regulation. Proc. Natl. Acad. Sci. U.S.A. 97, 10763-10768.
16. Louis J.C., Revel M.O., Zwiller J. Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC-12 cell. Biochim. Biophys. Acta. 1177:1993;299-306
17. Loughney K., Hill T.R., Florio V.A., Uher L., Rosman G.J., Wolda S.L., Jones B.A., Howard M.L., McAllister-Lucas L.M., Sonnenburg W.K., Francis S.H., Corbin J.D., Beavo J.A., Ferguson K. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase. Gene. 17:1998;139-147
18. Lucas K.A., Pitari G.M., Kazerounian S., Ruiz-Stewart I., Park J., Schulz S., Chepenik K.P., Waldman S.A. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52:2000;375-413
19. Murthy K. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle. Biochem. J. 360:2001;199-208
20. Murthy K.S., Makhlouf G.M. Interaction of cA-kinase and cG-kinase in mediating relaxation of dispersed smooth muscle cells. Am. J. Physiol. 268:1995;C171-C180
21. q. J. Biol. Chem. 272:1997;21317-21324
22. Murthy K.S., Teng B., Jin J.G., Makhlouf G.M. G protein-dependent activation of smooth muscle eNOS mediated by the natriuretic peptide-C receptor. Am. J. Physiol. 275:1998;C1409-C1416
23. Murthy K.S., Zhou H., Makhlouf G.M. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle. Am. J. Physiol. 282:2002;C508-C517
24. Murthy K.S., Zhou H. Selective phosphorylation of the IP3R-I in vivo by cGMP-dependent protein kinase in smooth muscle. Am. J. Physiol. 284:2003;G221-G230
25. Nakane M., Murad F. Cloning of guanylyl cylcase isoforms. Adv. Pharmacol. 26:1994;7-18
26. Papapetropoulos A., Marczin N., Mora G., Milici A., Murad F., Catravas J.D. Regulation of vasculat smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents. Hypertension. 26:1995;696-704
27. Soderling S.H., Beavo J.A. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr. Opin. Cell Biol. 12:2000;174-179
28. Strassheim D., Williams C.L. P2Y2 purinergic and M3 muscarinic acetylcholine receptors activate different phospholipase C-beta isoforms that are uniquely susceptible to protein kinase C-dependent phosphorylation and inactivation. J. Biol. Chem. 275:2000;39767-39772
29. Wedel B., Harteneck C., Foerster J., Friebe A., Schultz G., Koesling D. Functional domains of soluble Guanylyl cylcase. J. Biol. Chem. 270:1995;24871-24875
30. Wyatt T.A., Naftilan A.J., Francis S.H., Corbin J.D. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells. Am. J. Physiol. 274:1998;H448-H455
31. Zhang L., Tinett S., Robichon A. Drosophila NO-dependent guanylyl cyclase in finely regulated by sequential orser of coincidental signaling. J. Cell. Biochem. 85:2002;392-402
32. Zwiller J., Revel M.O., Basset P. Evidence for phosphorylation of rat brain guanylate cyclase by cAMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 101:1981;1381-1387
33. Zwiller J., Revel M.O., Malviya A.N. Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro. J. Biol. Chem. 260:1985;1350-1353